Study of Cardamom powder effect on the severity of nausea and vomiting in pregnant women referred to health centers in Chalus city 1389-90

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107016928N1

Enrollment

120

Registered

2011-08-03

Start date

2011-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting of pregnancy. Mild Hyperemesis gravidarum, mild or unspecified, starting before the end of the 22nd week of gestation

Interventions

Intervention 1: Intervention group: Cardamom powder capsules 500 mg, three times a day orally for 4 days. Intervention 2: Control group: Placebo capsules 500 mg contained Lactose, three times a day or

Treatment - Drugs

Placebo

Intervention group: Cardamom powder capsules 500 mg, three times a day orally for 4 days.

Control group: Placebo capsules 500 mg contained Lactose, three times a day orally for 4 days.

Eligibility

Sex/Gender

Female

Age

15 Years to 44 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Research units are Iranian and they have literacy in reading and writing; Singleton and normal pregnancy with 6 to 22 weeks based on LMP and ultrasound; Not having molar pregnancy;Not having symptoms of Threatened abortion; Not having acute Pyelonephritis; Not having Thyroid dysfunction; Not having identified digestive diseases which may cause nausea and vomiting; having a normal pregnancy based on documents that be existing in health centers; Having mild to moderate nausea and vomiting without hyperemsis gravidarum symptoms; Not to use anti emetic or emetic drugs( herbal or chemical drugs); Not to use tobacco; Not having psychological problems and unpleasant event over 6 months ago according to pregnant women reporting; Not unexpected pregnancy according to pregnant women reporting. Exclusion criteria: Not taking two courses of drug or more and to use anti emetic herbal or chemical drugs during study; Having Threatened abortion; Having spotting and severe nausea and vomiting which is required to treatment; Having Cardamom powder consumption in daily diet.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of nausea and vomiting of pregnancy. Timepoint: Before, during and after intervention. Method of measurement: Modified pregnancy- unique quantification of Emesis/ Nausea( PUQE).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGity Ozgoli

Nursing and Midwifery Faculty, Shahid Beheshti University of Medical Sciences

gozgoli@yahoo.com+98 21 8820 2512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026